11/5/00 PHR912 Biochemistry- Exam III
Learning Objectives for Dr. Howard's lectures
Chapter
12: DNA replication and repair
1.
Case
study (handout)
a)
Why
chemotherapeutic agents work.
b)
What
are chemotherapeutic agents.
c)
How
the new generation of anticancer drugs and diagnostic tests differ from
classical agents.
2.
Chpt.
12,pg. 167-173. Please be able to
define:
a)
the
process behind DNA replication.
b)
the
necessary components and enzymes for DNA replication.
c)
where
in the cell cycle does DNA replication occur.
3.
DNA
repair mechanisms, pg. 173-179:
a)
Why
is DNA repair important?
b)
What
is the etiology of cancer?
c)
Where
in the cell cycle does DNA repair occur?
Chapter
13: Transcription: Synthesis of RNA
1.
Chpt.
13, pg. 183-198. Please be able to
describe:
a)
what
transcription refers to? what enzymes
and components are involved?
b)
what
are the main types of RNA.
c)
where
does transcription take place in eukaryotes? in prokaryotes?
d)
what
are the two main steps of regulation of message levels?
2.
Case
studies (Chpt. 13):
a)
What
are the main targets for the inhibition by the antibiotics Rifamycin B and a-amanitin?
b)
Why
aren’t antibiotics such as Norfloxacin or Rifamycin B used to stop viral
infections? (Hint: biochemical comment at the back of Chpt. 13)
c)
How
does the lack of proofreading ability lead to cancer? AZT drug resistance?
d)
What
cells are affected in an inherited disease as in Annie Myck’s case versus an
acquired disease as in the cases for Ivy Sharer or Colin Tuma?
Chapter
14: Translation: Protein Synthesis
1. Chpt. 14, pg. 199-214. Please be able to describe:
a)
what
are the characteristics of the genetic code?
b)
what
are the components required for aminoacylation? for translation?
c)
where
in the cell does translation occur? how
does the function of the protein influence where it is synthesized in the cell?
3.
Case
studies (Chpt. 14):
a)
Why
do antibiotics work? What are the targets of action of the antibiotics
discussed in the biochemical comment at the end of Chpt.14?
b)
What
type of mutation causes sickle-cell anemia?
How does it affect the patient?
c)
At
what levels can mutations ultimately affect the levels of b-globin seen in b-thallesemia?
d)
Why
aren’t chemotherapeutic agents used to stop bacterial growth?
e)
Why
is diptheria toxin (from a bacterial virus) lethal in eukaryotes?